(AKBA) Akebia Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Akebia Therapeutics | (AKBA) share price targets
Complete technical analysis of Akebia Therapeutics (AKBA) by charts plus indicators, forecast predictions and share price targets for Akebia Therapeutics (AKBA)
Akebia Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Akebia Therapeutics is 6130656
| Date | Daily Closing Price | Open | High | Low | Volume |
| 31 Fri Oct 2025 | 2.21 | 2.11 | 2.23 | 2.07 | 0.997 times |
| 31 Fri Oct 2025 | 2.21 | 2.11 | 2.23 | 2.07 | 0.997 times |
| 30 Thu Oct 2025 | 2.10 | 2.09 | 2.32 | 2.07 | 1.494 times |
| 29 Wed Oct 2025 | 2.10 | 2.16 | 2.56 | 2.08 | 4.203 times |
| 28 Tue Oct 2025 | 3.09 | 3.20 | 3.20 | 3.07 | 1.034 times |
| 27 Mon Oct 2025 | 3.17 | 3.06 | 3.19 | 3.05 | 0.389 times |
| 24 Fri Oct 2025 | 3.03 | 3.00 | 3.07 | 2.98 | 0.221 times |
| 23 Thu Oct 2025 | 2.98 | 3.00 | 3.05 | 2.96 | 0.249 times |
| 22 Wed Oct 2025 | 2.99 | 3.09 | 3.10 | 2.93 | 0.425 times |
| 21 Tue Oct 2025 | 3.12 | 3.16 | 3.18 | 3.06 | 0.553 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 2.5, but if it comes above 2.5, then a intra day buy could be more profitable.
If you take a sell trade below 2.5, then use 2.5 as stoploss and 2 as target. However if you take a buy trade in stock , then use 2.5 as stoploss and 2.8 as target.
Share price targets for Akebia Therapeutics (AKBA)
| Target Type | Value |
| Downside Target | 2.07 |
| Upside Target | 2.23 |
| Upside Target | 2.66 |
| Upside Target | 2.75 |
| Upside Target | 2.91 |
| Upside Target | 3.10 |
| Upside Target | 3.18 |
| Upside Target | 3.20 |
| Upside Target | 3.22 |
| Upside Target | 3.47 |
| Upside Target | 3.79 |
| Upside Target | 4.08 |
Intraday share price targets for Akebia Therapeutics (AKBA)
| Target Type | Value |
| Downside Intraday Target | 2.11 |
| Downside Intraday Target | 2.01 |
| Upside Intraday Target | 2.27 |
| Upside Intraday Target | 2.33 |
| Downside Intraday Target | 2.17 |
Weekly technical analysis of Akebia Therapeutics (AKBA)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 31 Fri Oct 2025 | 2.21 | 2.11 | 2.23 | 2.07 | 0.123 times |
| 31 Fri Oct 2025 | 2.21 | 3.06 | 3.20 | 2.07 | 4.313 times |
| 24 Fri Oct 2025 | 3.03 | 2.96 | 3.18 | 2.91 | 0.948 times |
| 17 Fri Oct 2025 | 2.93 | 2.77 | 3.10 | 2.69 | 0.812 times |
| 10 Fri Oct 2025 | 2.75 | 2.85 | 3.02 | 2.75 | 1.357 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Akebia Therapeutics (AKBA)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 31 Fri Oct 2025 | 2.21 | 2.72 | 3.20 | 2.07 | 1.375 times |
| 30 Tue Sep 2025 | 2.73 | 3.07 | 3.22 | 2.66 | 0.837 times |
| 29 Fri Aug 2025 | 3.14 | 3.65 | 3.79 | 2.92 | 1.24 times |
| 31 Thu Jul 2025 | 3.69 | 3.63 | 4.08 | 3.47 | 0.572 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Akebia Therapeutics (AKBA)
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Akebia Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Akebia Therapeutics in short term and the sell signal is strong.
Akebia Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Akebia Therapeutics in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Akebia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.39 and Akebia Therapeutics (AKBA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Akebia Therapeutics (AKBA) stock. Volume based technical analysis of Akebia Therapeutics (AKBA) stock is negative.
Akebia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Akebia Therapeutics ( (AKBA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Akebia Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Akebia Therapeutics in short term and the sell signal is strong.
Akebia Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Akebia Therapeutics in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Akebia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.39 and Akebia Therapeutics (AKBA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Akebia Therapeutics (AKBA) stock. Volume based technical analysis of Akebia Therapeutics (AKBA) stock is negative.
Akebia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.